Home
Frontier Biotechnologies Inc.

Frontier Biotechnologies... Market Share Analysis for May 2026

前沿生物药业（南京）股份有限公司

Industry: N/A

Domainfrontierbiotech.com

Year Founded2002

Employees201 - 500

Annual Revenue$15M - $25M

Frontier Biotechnologies Inc.

Frontier Biotechnologies Inc. (including company regionals)

frontierbiotech.com

See more website traffic and engagement information

Frontier Biotechnologies Inc. Revenue up to May 2026 is 15M - 25M

revenue generated by Frontier Biotechnologies Inc. top domains

Frontier Biotechnologies Inc. top domains revenue over 3 years

Revenue for Frontier Biotechnologies Inc. top domains

frontierbiotech.com15M - 25M

See more with Sales Intelligence

Total visits to Frontier Biotechnologies Inc.'s top domains

Understand Frontier Biotechnologies Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

frontierbiotech.com357

See more with Sales Intelligence

Avg. visit duration in Frontier Biotechnologies Inc.'s top domains

Analyze Frontier Biotechnologies Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

frontierbiotech.com00:00:58

See more with Sales Intelligence

Avg. pageviews on Frontier Biotechnologies Inc.'s top domains

See how Frontier Biotechnologies Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

frontierbiotech.com1.79

See more with Sales Intelligence

Frontier Biotechnologies Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Frontier Biotechnologies Inc.

These are the website technologies, by industry, used by Frontier Biotechnologies Inc. top domains

Mobile (3)

Meta Viewport

Social (2)

Baidu Share

Advertising (1)

PubMatic

Widget (1)

Baidu Maps

News & Signals from Frontier Biotechnologies Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFrontier Biotech sells assets to GlaxoSmithKline in the amount of $1B.The acquisition agreement comes a day after GSK added two small interfering RNA assets from Nanjing, China-based Frontier Biotechnologies Inc. through a license deal reaching up to $1 billion.

NewsAFFiRiS AG partnered with Frontier Biotech on Dec 22nd '21.AFFiRiS AG, a clinical-stage biotechnology company developing novel disease-modifying Specific Active Immunotherapies (SAITs), today announced an exclusive collaboration and license agreement with Frontier Biotechnologies Inc. (688221.

NewsFrontier Biotech hires Jing Bao as Vice President Clinical Development.Dr. Jing Bao was appointed to Vice President Clinical Development at Frontier Biotech.